Este evento es organizado por IFPMA, CETIFARMA, AMIIF, CANIFARMA y FIFARMA.

Sede: Salón Reforma, Hotel Barceló Reforma.

Cupo limitado, por lo que se dará prioridad a las personas conforme se vayan registrando. Se podrán registrar máximo dos personas por empresa.

Las organizaciones involucradas financiarán el evento, por lo que las personas que se registren se comprometen a permanecer y participar en todo el taller.

Hands-on Code Capacity Workshop

Following successful Code Capacity Workshops in locations such as Accra, Beijing, Johannesburg, Dubai and Manila, the global association of the research-based pharmaceutical industry (www.ifpma.org) has selected Mexico City to deliver a hands-on training on the recently launched revised Code of Practice and to engage in a broader discussion about the progress and the future of ethics & business integrity in Mexico and Latin America as a whole – with regional and international IFPMA experts.

Hands-on | Code Capacity Workshop. April 2, from 09:00 – 17:30 (incl. lunch & networking cocktail)

Workshop Objectives

The workshop has been designed to provide “business case” exposure to participants on day to day topics including:

  • How to properly interact with Healthcare Professionals (doctors, nurses, pharmacists etc.) for promotional and medical information sharing.
  • Increasing the level of ethical conduct of activities in your organization.
  • Insights on how to set up and run a successful compliance program in your organization.
  • Interactions with patient organizations.
  • Activities like commissioning and creation of promotional material and writing and approving copy and artwork.
  • Determining promotional methods including: professional representation, hospitality to doctors and the use of audio-visual and related communications technology in the organization of international educational events.

The workshop will be based on the new IFPMA Code of Practice (effective Jan 1, 2019) which forms the basis for national codes of practice within Mexico, Latin America and worldwide. Participants will receive an update on the Code and the respective interpretation – trainers are keen to engage and exchange with the audience on local implementation.

Who Should Attend?

  • Anybody within a biopharmaceutical company who is responsible for medical or commercial activities with HCPs and or HCOs, who supports the business with the interpretation of current local or global standards or who is part of the review or approval process for these activities
  • Representatives from national pharmaceutical trade associations
  • Ethics & Compliance professionals
  • Medical and Scientific advisors and directors
  • Personnel responsible for the development and
  • certification of promotional materials
  • Sales and marketing representatives
  • General managers
  • In-house counsel and other related staff

Featured regional faculty

  • Erika Almeida | LatAm Quality & Risk Management Director, GSK.
  • Marco Escotto | Executive Secretary of Council of Ethics & Transparency (CETIFARMA).
  • Carolina Gracida | Ethics & Business Integrity Manager, Mexico, Sanofi.
  • Claudia Hernández | LATAM Area Director, Office of Ethics and Compliance, AbbVie.
  • Dr. Juan Francisco Millán | Executive Secretary of Council of Ethics & Transparency (CETIFARMA).
  • Carolina Naboni | Regional Compliance Officer LATAM, Merck.
  • Olga Sanz | Ethics & Compliance Manager for Iberia and Latin America, Ipsen.
  • Cynthia Vatrano | Country Compliance Head Mexico, Novartis.
  • Lucia Villamil Mariatti | Head of Legal & Compliance. Central America & the Caribbean, Roche.
  • Holger Diener | Managing Director, Association of Voluntary Self-Regulation for the Pharmaceutical Industry, Germany and Vice-Chair of the Ethics and Business Integrity Committee of IFPMA, Switzerland.
  • Karen Eryou | Head, Ethics and Compliance Programs, UCB Pharma, Former Co-chair, Asia Pacific Pharma Compliance Congress, Belgium.
  • Loreto Fernandez | Secondee, Ethics & Business Integrity, IFPMA, Switzerland and Legal & Healthcare Compliance Advisor, Farmaindustria, Spain.
  • Dominique Laymand | Executive Vice-President and Global Chief Ethics & Compliance, Ipsen, France.
  • Sofie Melis | Head of Ethics & Compliance, IFPMA, Switzerland.
  • Hannes Oswald-Brügel | Head Pharma Healthcare Compliance Office, Roche, Switzerland.
  • José Zamarriego | Director, Code Surveillance Unit, Farmaindustria, Spain.

This workshop is free of charge – all time and effort is donated by IFPMA and its member companies and associations.

Workshop capacity is limited and registration confirmation will be on a first-come first-served basis. Once registered, a space will be assigned to you. Therefore, please make sure you can come or let the organizers know so your place can be given to someone on the waiting list. You can access the registration platform here.

Integridad y transparencia en el sector biofarmacéutico

Este evento es organizado por IFPMA, CETIFARMA, AMIIF, CANIFARMA y FIFARMA.

Sede: Palacio de la Escuela de Medicina. Salón: Paraninfo
El objetivo es establecer un diálogo entre la industria farmacéutica con diferentes actores del sistema de salud: profesionales de la salud, organizaciones de pacientes y autoridades.

Cupo limitado, por lo que se dará prioridad a las personas conforme se vayan registrando.

Las organizaciones involucradas financiarán el evento, por lo que las personas que se registren se comprometen a permanecer en todo el foro.